KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestMortgage LoansNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesReal Estate - NetRetained EarningsShareholder's EquityTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sabra Health Care REIT (SBRA) Cash & Equivalents (2016 - 2025)

Sabra Health Care REIT (SBRA) has 15 years of Cash & Equivalents data on record, last reported at $71.5 million in Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 18.31% year-over-year to $71.5 million; the TTM value through Dec 2025 reached $71.5 million, up 18.31%, while the annual FY2025 figure was $71.5 million, 18.31% up from the prior year.
  • Cash & Equivalents reached $71.5 million in Q4 2025 per SBRA's latest filing, down from $200.6 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $546.3 million in Q3 2021 and bottomed at $22.7 million in Q1 2025.
  • Average Cash & Equivalents over 5 years is $83.3 million, with a median of $54.6 million recorded in 2022.
  • Peak YoY movement for Cash & Equivalents: surged 1459.45% in 2021, then crashed 95.19% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $112.0 million in 2021, then plummeted by 55.97% to $49.3 million in 2022, then dropped by 16.27% to $41.3 million in 2023, then surged by 46.46% to $60.5 million in 2024, then increased by 18.31% to $71.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $71.5 million in Q4 2025, $200.6 million in Q3 2025, and $95.2 million in Q2 2025.